SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001437749-10-001102
Filing Date
2010-04-16
Accepted
2010-04-15 17:50:48
Documents
1
Group Members
DOUGLAS A. MCCLAIN, JR.JAMES T. MICELI

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 argyllbio_sc13da5-immunosyn.htm SC 13D/A 141009
  Complete submission text file 0001437749-10-001102.txt   142931
Mailing Address 4225 EXECUTIVE SQUARE SUITE 260 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 260 LA JOLLA CA 92037 858-200-2320
ARGYLL BIOTECHNOLOGIES LLC (Filed by) CIK: 0001374946 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address 4225 EXECUTIVE SQUARE SUITE 260 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 260 LA JOLLA CA 92037 858-200-2320
IMMUNOSYN CORP (Subject) CIK: 0001375623 (see all company filings)

IRS No.: 205322896 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82677 | Film No.: 10753114
SIC: 2836 Biological Products, (No Diagnostic Substances)